top of page
Discuss with coworkers

Case Studies

Selected Engagements (2022 - Present)

NASDAQ-listed Consumer-driven AI/e-commerce platform

Provided strategic guidance to the management and board of a publicly-traded AI/ecommerce focused technology company; leveraged strong network and connectivity to secure a high value IPO investment indication in a time-sensitive and high-pressure environment; further advised on capital markets initiatives, helping the company to secure up to an aggregate of ~$65mm in term sheets from multiple investors.

NASDAQ-listed Immunology Company

Led capital markets strategy for a distressed publicly-traded Immunology company, helping to secure $1M in bridge financing to help the company circumvent bankruptcy; currently assisting with corporate M&A and acquisitions.

NASDAQ-listed Oncology Company

Provided capital markets expertise and executed strategic introductions that culminated in a term sheet for up to $14 million in financing from an institutional investor.

Original (1)_edited.png
  • LinkedIn

DISCLAIMER

Unless otherwise agreed to in writing, any communications in any form or medium, from Dharma Capital Advisors, LLC (“Dharma Capital”) are intended solely for informational purposes and should not be construed as investment advice and are not meant to be a solicitation or recommendation to buy, sell, or hold any securities or businesses mentioned.

© 2025 Dharma Capital Advisors. All Rights Reserved.

bottom of page